Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Aerie Pharmaceuticals Inc (AERI)  
$15.25 0.00 (0.00%) as of 4:30 Fri 11/18


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 47,361,000
Market Cap: 722.26(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $15.25 - $15.25
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Aerie Pharmaceuticals is a pharmaceutical company focused on the discovery, development and commercialization of ophthalmic therapies for the treatment of patients with eye diseases and conditions including open-angle glaucoma, dry eye, and diabetic macular edema. Rhopressa® is a once-daily eye drop designed to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Rocklatan® is a once-daily fixed-dose combination of Rhopressa® and latanoprost, a prescribed drug for the treatment of patients with open-angle glaucoma or ocular hypertension. Co. is developing AR-15512, an ophthalmic solution for the treatment of patients with dry eye disease.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 333
  Page 8 of 14  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kopczynski Casey C. Chief Scientific Officer   •       –      –    2019-02-23 4 D $40.04 $13,133 D/D (328) 102,714     -
   Larocca John General Counsel   •       –      –    2019-02-19 4 D $40.80 $62,914 D/D (1,542) 23,458     -
   Mitro Thomas A President and COO   •       –      –    2019-02-08 4 D $40.39 $50,124 D/D (1,241) 63,016     -
   Rubino Richard J Chief Financial Officer   •       –      –    2019-02-08 4 D $40.39 $41,844 D/D (1,036) 326,762     -
   Kopczynski Casey C. Chief Scientific Officer   •       –      –    2019-02-08 4 D $40.39 $28,313 D/D (701) 103,042     -
   Anido Vicente Jr Chief Executive Officer   •       •      –    2019-02-08 4 D $40.39 $65,593 D/D (1,624) 150,109     -
   Mitro Thomas A President and COO   •       –      –    2019-02-07 4 A $0.00 $0 D/D 12,778 64,257     -
   Rubino Richard J Chief Financial Officer   •       –      –    2019-02-07 4 A $0.00 $0 D/D 10,667 327,798     -
   Kopczynski Casey C. Chief Scientific Officer   •       –      –    2019-02-07 4 A $0.00 $0 D/D 8,000 103,743     -
   Anido Vicente Jr Chief Executive Officer   •       •      –    2019-02-07 4 A $0.00 $0 D/D 25,413 151,733     -
   Larocca John General Counsel   •       –      –    2019-02-07 4 A $0.00 $0 D/D 7,000 25,000     -
   Kopczynski Casey C. Chief Scientific Officer   •       –      –    2019-02-01 4 AS $46.03 $507,844 D/D (11,000) 95,743     -
   Kopczynski Casey C. Chief Scientific Officer   •       –      –    2019-01-02 4 AS $35.21 $387,313 D/D (11,000) 106,743     -
   Kopczynski Casey C. Chief Scientific Officer   •       –      –    2018-12-03 4 AS $39.79 $437,894 D/D (11,000) 117,743     -
   Cagle Gerald D. Director   –       •      –    2018-11-16 4 B $41.75 $83,493 D/D 2,000 19,800 2.39     -
   Kopczynski Casey C. Chief Scientific Officer   •       –      –    2018-11-01 4 AS $52.99 $592,521 D/D (11,000) 128,743     -
   Kopczynski Casey C. Chief Scientific Officer   •       –      –    2018-10-01 4 AS $60.43 $666,204 D/D (11,000) 136,517     -
   Rubino Richard J Chief Financial Officer   •       –      –    2018-09-27 4 AS $60.36 $1,002,386 D/D (16,605) 317,131     -
   Rubino Richard J Chief Financial Officer   •       –      –    2018-09-26 4 AS $60.18 $3,009,445 D/D (50,000) 333,736     -
   Rubino Richard J Chief Financial Officer   •       –      –    2018-09-14 4 AS $60.00 $120 D/D (2) 383,736     -
   Rubino Richard J Chief Financial Officer   •       –      –    2018-09-13 4 S $60.17 $2,076,608 D/D (34,512) 383,738     -
   Kopczynski Casey C. Chief Scientific Officer   •       –      –    2018-09-04 4 S $60.00 $661,024 D/D (11,000) 147,517     -
   Mitro Thomas A President and COO   •       –      –    2018-08-27 4 AS $60.27 $11,451,006 D/D (190,000) 51,479     -
   Mitro Thomas A President and COO   •       –      –    2018-08-27 4 OE $3.15 $598,500 D/D 190,000 241,479     -
   Kopczynski Casey C. Chief Scientific Officer   •       –      –    2018-08-01 4 S $68.00 $751,298 D/D (11,000) 158,517     -
  333 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 8 of 14
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us